Skip to main content
Clinical Trials/NCT02598765
NCT02598765CompletedNot Applicable

Micro vs. Standard Trabeculectomy Study

University of California, San Francisco1 site in 1 country100 target enrollmentStarted: April 4, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Cumulative incidence of complications

Study Overview

Brief Summary

The purpose of this study is to determine the reduction in intraocular pressure and cumulative incidence of complications between the standard and micro trabeculectomy surgeries 3 months after surgery.

Detailed Description

This study is a randomized, double-masked (study participants and outcome assessors) trial. During the enrollment period, consecutive patients from LEI who are planning to have trabeculectomy surgery and who meet the study enrollment criteria will be randomized to receive standard trabeculectomy or microtrabeculectomy. The primary outcome is complications and change in intraocular pressure after a 3 month follow-up period. We will perform subgroup analyses by stratifying the population according to skin pigmentation to determine whether pigmentation is a predictor of treatment success.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age >= 40
  • •Planning to have a trabeculectomy

Exclusion Criteria

  • •Life threatening or debilitating disease
  • •Inability to complete necessary exams and/or ocular disease that would preclude assessment of intraocular pressure, visual field, or optic disc
  • •Contralateral eye already enrolled in study

Arms & Interventions

Standard Trabeculectomy

Active Comparator

Patients in the Standard Trabeculectomy arm will undergo regular trabeculectomy

Intervention: Standard Trabeculectomy (Procedure)

Microtrabeculectomy

Experimental

Patients in the Microtrabeculectomy arm will undergo microtrabeculectomy

Intervention: Microtrabeculectomy (Procedure)

Outcomes

Primary Outcomes

Cumulative incidence of complications

Time Frame: 3 months after surgery

Comparison of the cumulative incidence of complications between the treatment groups (regular and micro trabeculectomy) 3 months after surgery

Secondary Outcomes

  • Cumulative incidence of complications(6 and 12 months after surgery)
  • Reduction in intraocular pressure(3 months after surgery)
  • Reduction of intraocular pressure(6 and 12 months after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor
Principal Investigator

Jeremy Keenan

Associate Professor

University of California, San Francisco

Study Sites (1)

Loading locations...

Similar Trials